Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
-
2022 WS
-
2022 SS
-
2021 WS
-
2021 SS
-
2020 WS
-
2020 SS
-
2019 WS
-
2019 SS
-
2018 WS
-
2018 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients : 52-week efficacy and safety results of the phase 3 randomized controlled NOPHOS trialIn: Nephrology Dialysis Transplantation (NDT) Jg. 38 (2022) Nr. 4, S. 982 - 991ISSN: 1460-2385; 0931-0509Online Volltext: dx.doi.org/ (Open Access)
-
Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapyIn: Endocrine Jg. 75 (2022) Nr. 1, S. 293 - 302ISSN: 1559-0100; 1355-008X; 0969-711XOnline Volltext: dx.doi.org/ (Open Access)
-
Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis—A Randomized Clinical TrialIn: Kidney International Reports Jg. 6 (2021) Nr. 3, S. 594 - 604ISSN: 2468-0249Online Volltext: dx.doi.org/ (Open Access)
-
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma : results from the PETAL trialIn: Journal of Cancer Research and Clinical Oncology (2021) in pressISSN: 1432-1335; 0171-5216; 0084-5353; 0301-1585Online Volltext: dx.doi.org/ (Open Access)
-
Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations : Comparison of the Deauville 5-Point Scale and the ΔSUVmₐₓ MethodIn: Journal of Nuclear Medicine (JNM) / Society of Nuclear Medicine and Molecular Imaging (SNMMI) (Hrsg.) Jg. 62 (2021) Nr. 1, S. 37 - 42ISSN: 1535-5667; 0161-5505; 2159-662X; 0022-3123; 0097-9058Online Volltext: dx.doi.org/ (Open Access)
-
Smoking cessation potential among newly diagnosed cancer patients : A population-based study of the ten most common cancers in Massachusetts, USA, 2008–2013In: Annals of Epidemiology Jg. 56 (2021) S. 55 - 60.e11ISSN: 1873-2585; 1047-2797Online Volltext: dx.doi.org/
-
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trialIn: Hematological Oncology (2020)ISSN: 0278-0232; 1099-1069Online Volltext: dx.doi.org/ (Open Access)
-
CSF and blood Kallikrein-8 : A promising early biomarker for Alzheimer's diseaseIn: Journal of Neurology, Neurosurgery and Psychiatry Jg. 91 (2020) Nr. 1, S. 40 - 48ISSN: 1468-330X; 0022-3050Online Volltext: dx.doi.org/ (Open Access)
-
Corrigendum to ‘Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial’ [Eur J Canc 124 (January 2020) 25–36] (European Journal of Cancer (2020) 124 (25–36), (S0959804919307555), (10.1016/j.ejca.2019.09.027))In: European Journal of Cancer (EJC) Jg. 136 (2020) S. 207 - 208ISSN: 1879-0852; 0959-8049Online Volltext: dx.doi.org/ (Open Access)
-
Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma : Post-hoc analysis from the PETAL trialIn: European Journal of Cancer Jg. 124 (2020) S. 25 - 36ISSN: 1879-0852; 0959-8049Online Volltext: dx.doi.org/
-
Metabolic tumor volume, cancer cell fraction, and prognosis–the case of T-cell/histiocyte-rich large B-cell lymphomaIn: Leukemia and Lymphoma Jg. 61 (2020) Nr. 6, S. 1372 - 1379ISSN: 1029-2403; 1042-8194Online Volltext: dx.doi.org/
-
Score performance of SAPS 2 and SAPS 3 in combination with biomarkers IL-6, PCT or CRPIn: PLoS ONE Jg. 15 (2020) Nr. 9, S. e0238587ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determinationIn: Data in Brief Jg. 28 (2020)ISSN: 2352-3409Online Volltext: dx.doi.org/ (Open Access)
-
Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial : correlation with interim PET and outcomeIn: Blood Cancer Journal Jg. 9 (2019) Nr. 9, S. 67ISSN: 2044-5385Online Volltext: dx.doi.org/ (Open Access)
-
Pharmacological properties of the novel nicotinamide modified release preparation nophos as complementary treatment option for hyperphosphatemia in hemodialysis petientsIn: Nephrology Dialysis Transplantation Jg. 34 (2019) Nr. Suppl. 1, S. 559ISSN: 0931-0509; 1460-2385Online Volltext: dx.doi.org/
-
Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma : Study protocol for a multicentric randomized controlled trialIn: Trials Jg. 20 (2019) Nr. 1, S. 99ISSN: 1745-6215; 1468-6694; 1468-6708Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP : results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trialIn: Annals of Hematology Jg. 98 (2019) Nr. 4, S. 897 - 907ISSN: 1432-0584; 0939-5555; 0006-5242Online Volltext: dx.doi.org/
-
The predictive performance of SAPS 2 and SAPS 3 in an intermediate care unit for internal medicine at a German university transplant center : A retrospective analysisIn: PLoS ONE Jg. 14 (2019) Nr. 9,ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
Eculizumab in cold agglutinin disease (DECADE) : an open-label, prospective, bicentric, nonrandomized phase 2 trial.In: Blood Advances Jg. 2 (2018) Nr. 19, S. 2543 - 2549ISSN: 2473-9537; 2473-9529Online Volltext: dx.doi.org/ (Open Access)
-
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) : A Multicenter, Randomized Phase III TrialIn: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 20, S. 2024 - 2034ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Reply to H.J.A adams et al and C. GisselbrechtIn: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 32, S. 3273 - 3274ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Phase II dose–response trials : A simulation study to compare analysis method performance under design considerationsIn: Journal of Biopharmaceutical Statistics Jg. 27 (2017) Nr. 5, S. 885 - 901ISSN: 1520-5711; 1054-3406Online Volltext: dx.doi.org/
-
Arthroscopic three-dimensional autologous chondrocyte transplantation using spheroids for the treatment of full-thickness cartilage defects of the hip jointIn: Knee Surgery, Sports Traumatology, Arthroscopy Jg. 24 (2016) Nr. 6, S. 2032 - 2037ISSN: 1433-7347; 0942-2056Online Volltext: dx.doi.org/
-
Is early treatment of cam-type femoroacetabular impingement the key to avoiding associated full thickness isolated chondral defects?In: Knee Surgery, Sports Traumatology, Arthroscopy Jg. 24 (2016) Nr. 7, S. 2332 - 2337ISSN: 0942-2056Online Volltext: dx.doi.org/
-
Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive LymphomasIn: Blood Jg. 126 (2015) Nr. 23,ISSN: 1528-0020; 0006-4971
-
Positron Emission Tomography guided therapy of aggressive lympomas (PETAL) - the predictive value of quantitative PETIn: Journal of Nuclear Medicine Jg. 56 (2015) Nr. Suppl. 3, S. 210ISSN: 0161-5505; 1535-5667
-
Outcome of aggressive lymphoma patients with a negative pretreatment positron emission tomography scanIn: Haematologica Jg. 99 (2014) Nr. Suppl. 1, 19th Congress of the European Hematology Association, Milan, Italy, June 12–15, 2014, S. 151ISSN: 0390-6078; 1592-8721(Open Access)
-
Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)In: Blood Jg. 124 (2014) Nr. 21, S. 391ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/
-
Dynamic model for risk assessment in diffuse large B-cell lymphoma based on positron emission tomography scanning
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 67ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
Interim PET-Based Outcome Prediction in Diffuse Large B-Cell Lymphoma Patients Participating in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) Trial : Comparison of the Delta SUV Max Method and the Deauville 5-Point Scale
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 1696 - 1696ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/ -
Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL Trial
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 4188 - 4188ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ (Open Access) -
Diagnostic performance of 1,3-beta-D-glucan serum screening in patients after liver transplantationIn: Mycoses Jg. 59 (2016) Nr. Suppl. 2, S. 20ISSN: 1439-0507; 0933-7407; 0027-5557Online Volltext: dx.doi.org/
-
Developing a prognostic risk score for patients with newly diagnosed aggressive Non-Hodgkin Lymphoma : clinical and statistical issuesDuisburg, Essen (2019) 91 BlätterOnline Volltext: dx.doi.org/ Online Volltext (Open Access)